CASPIAN THERAPEUTICS Trademark

Trademark Overview


On Wednesday, October 11, 2023, a trademark application was filed for CASPIAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CASPIAN THERAPEUTICS trademark a serial number of 98219075. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, March 4, 2024. This trademark is owned by Kura Oncology, Inc.. The CASPIAN THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions

Providing medical and scientific research information in the field of treatment of oncological diseases, disorders, and conditions, and clinical trials and post-market trials related to treatment of oncological diseases, disorders, and conditions; consulting services in the field of research and development of treatments of oncological diseases, disorders, and conditions; cancer treatment research and development
caspian therapeutics

General Information


Serial Number98219075
Word MarkCASPIAN THERAPEUTICS
Filing DateWednesday, October 11, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, March 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
Goods and ServicesProviding medical and scientific research information in the field of treatment of oncological diseases, disorders, and conditions, and clinical trials and post-market trials related to treatment of oncological diseases, disorders, and conditions; consulting services in the field of research and development of treatments of oncological diseases, disorders, and conditions; cancer treatment research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 16, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKura Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Saturday, October 14, 2023NEW APPLICATION ENTERED
Monday, February 26, 2024ASSIGNED TO EXAMINER
Monday, October 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 4, 2024NON-FINAL ACTION WRITTEN
Monday, March 4, 2024NON-FINAL ACTION E-MAILED
Monday, March 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 3, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, June 3, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED